Adaptive Bio Ownership | Who Owns Adaptive Bio?


OverviewForecastRevenueFinancialsChartTranscripts

Adaptive Bio Ownership Summary


Adaptive Bio is owned by 97.39% institutional investors, 2.34% insiders, and 0.27% retail investors. Viking global investors lp is the largest institutional shareholder, holding 19.72% of ADPT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.89% of its assets in Adaptive Bio shares.

ADPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAdaptive Bio97.39%2.34%0.27%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp29.99M19.72%$349.43M
Rubric capital management lp14.60M9.90%$87.53M
Blackrock funding, inc. /de13.36M8.78%$199.84M
Vanguard group11.28M7.41%$168.68M
Millennium management6.29M4.27%$37.72M
Braidwell lp3.86M2.54%$45.01M
Nikko asset management americas3.65M2.40%$54.65M
Sumitomo mitsui trust3.65M2.40%$54.61M
Geode capital management3.40M2.24%$50.89M
Ark investment management3.17M2.08%$47.36B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue water life science advisors, lp2.15M19.78%$24.99M
Braidwell lp3.86M1.54%$45.01M
Pier capital635.08K1.49%$9.50M
Essex investment management638.46K1.46%$9.55M
Rubric capital management lp14.60M1.12%$87.53M
Lisanti capital growth299.18K1.09%$4.48M
Aristotle atlantic partners2.88M1.02%$33.54M
Viking global investors lp29.99M1.01%$349.43M
Rhenman & partners asset management ab495.00K0.82%$7.41B
Affinity wealth management303.53K0.66%$4.54M

Top Buyers

HolderShares% AssetsChange
Fred alger management2.36M0.12%2.36M
Arrowstreet capital, limited partnership2.44M0.02%2.06M
Deutsche bank ag\1.71M0.01%1.54M
Macquarie group2.10M0.04%1.44M
Point72 asset management1.37M0.03%1.37M

Top Sellers

HolderShares% AssetsChange
Millennium management6.29M0.02%-3.11M
Braidwell lp3.86M1.54%-940.69K
Perceptive advisors---930.97K
Ark investment management3.17M0.28%-850.85K
Jpmorgan chase235.67K0.00%-799.25K

New Positions

HolderShares% AssetsChangeValue
Fred alger management2.36M0.12%2.36M$27.44M
Oberweis asset management inc/589.40K0.30%589.40K$6.87M
Rhenman & partners asset management ab495.00K0.82%495.00K$7.41B
Qube research364.77K0.00%364.77K$4.25M
Affinity wealth management303.53K0.66%303.53K$4.54M

Sold Out

HolderChange
Ronald blue trust-21.00
Northwestern mutual wealth management-24.00
Birch capital management-40.00
Stephens consulting-45.00
Srs capital advisors-97.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252437.05%148,113,052-1.78%970.95%13722.32%63-4.55%
Mar 31, 20252278.10%152,848,9696.73%1021.09%1130.89%6544.44%
Dec 31, 202420911.17%143,202,0650.07%971.03%11114.43%452.27%
Sep 30, 20241886.21%143,105,692-3.74%970.93%975.43%44-4.35%
Jun 30, 2024177-7.81%148,665,2304.35%1011.07%926.98%46-30.30%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.40M2.89%-94.13K
Vanguard US Total Market Shares ETF4.19M2.82%-
ARK Genomic Revolution3.93M2.58%-3.69M
iShares Russell 2000 ETF3.61M2.37%-
Nikko AM ARK Pstv Chg Innovt P JPY Acc3.56M2.34%-116.30K
Amova ARK Pstv Chg Innovt P JPY Acc3.35M2.20%-207.56K
Columbia Large Cap Growth3.25M2.19%3.25M
Columbia Large Cap Growth SMA Cmp3.25M2.19%3.25M
Columbia Large Cap Growth V3.25M2.19%3.25M
Columbia Cornerstone Growth SMA3.25M2.14%3.25M

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2025ROBINS HARLAN S Chief Scientific OfficerSell$148.20K
Nov 11, 2025ROBINS CHAD M CEO and ChairmanSell$18.02K
Nov 10, 2025ROBINS CHAD M CEO and ChairmanSell$1.27M
Nov 12, 2025ROBINS CHAD M CEO and ChairmanSell$28.00K
May 16, 2025PISKEL KYLE Chief Financial OfficerSell$17.15K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q2-3
2025 Q1-25
2024 Q4-1
2024 Q3-1

ADPT Ownership FAQ


Who Owns Adaptive Bio?

Adaptive Bio shareholders are primarily institutional investors at 97.39%, followed by 2.34% insiders and 0.27% retail investors. The average institutional ownership in Adaptive Bio's industry, Biotech Stocks , is 295.31%, which Adaptive Bio falls below.

Who owns the most shares of Adaptive Bio?

Adaptive Bio’s largest shareholders are Viking global investors lp (29.99M shares, 19.72%), Rubric capital management lp (14.6M shares, 9.90%), and Blackrock funding, inc. /de (13.36M shares, 8.78%). Together, they hold 38.40% of Adaptive Bio’s total shares outstanding.

Does Blackrock own Adaptive Bio?

BlackRock is not among the top 10 institutional shareholders of Adaptive Bio.

Who is Adaptive Bio’s biggest shareholder by percentage of total assets invested?

Blue water life science advisors, lp is Adaptive Bio’s biggest shareholder by percentage of total assets invested, with 19.78% of its assets in 2.15M Adaptive Bio shares, valued at 24.99M$.

Who is the top mutual fund holder of Adaptive Bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Adaptive Bio shares, with 2.89% of its total shares outstanding invested in 4.4M Adaptive Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools